2.95
price down icon30.09%   -1.27
after-market Dopo l'orario di chiusura: 3.02 0.07 +2.37%
loading

Alaunos Therapeutics Inc Azioni (TCRT) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
0.00%
0.001
0.001 - 0.004 -
Operating Expenses
78.08%
1.743
7.95 8.664 7.986 9.672
Interest Income/Expense
-
- - 1.068 0.853
Benefits Costs and Expenses
-
- - - -
Costs And Expenses
78.08%
1.743
7.95 8.665 7.986 9.671
Operating Income/Loss
78.09%
-1.742
-7.949 -8.664 -7.982 -9.672
Nonoperating Income/Loss
43.40%
0.06
0.106 0.188 -0.791 -0.376
Income/Loss From Continuing Operations Before Tax
0.00%
0.001
0.001 -8.476 0.004 -10.05
Income/Loss From Continuing Operations After Tax
78.55%
-1.682
-7.843 -8.476 -8.773 -10.05
Net Income/Loss
78.55%
-1.682
-7.843 -8.476 -8.773 -10.05
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
107.15%
16.01
-223.85 240.05 239.80 239.68
Diluted Average Shares
107.15%
16.01
-223.85 240.05 239.80 239.68
Basic Earnings Per Share
94.74%
-0.11
-2.09 -0.04 -0.04 -0.04
Diluted Earnings Per Share
94.74%
-0.11
-2.09 -0.04 -0.04 -0.04
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$60.58
price down icon 3.01%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
Capitalizzazione:     |  Volume (24 ore):